Estimation of time devoted to adverse drug reactions assessment in an internal medicine department

British Journal of Clinical Pharmacology

Volumn 60, Issue 4, 2005, Pages 452-453

  Tavassoli, Neda ^a   Bagheri, Haleh ^a,c   Sailler, Laurent ^b   Benkemoun, Philippe ^a   Montastruc, Jean Louis ^a   Arlet, Philippe ^b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b CHU PURPAN   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ASTHENIA; DRUG HYPERSENSITIVITY; DRUG SURVEILLANCE PROGRAM; HOSPITAL DEPARTMENT; HUMAN; LETTER; MEDICAL PRACTICE; MEDICAL STAFF; METABOLIC DISORDER; NEUROLOGIC DISEASE; PATIENT MONITORING; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG THERAPY; HUMANS; INTERNAL MEDICINE; TIME FACTORS;

EID: 26444463319     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02469.x     Document Type: Letter

References (4)

1. Classen DC, Pestotnik SL, Evans RS, Lloyd LF. Adverse drug events in hospitalized patients: excess length of stay, extra-costs, and attibuable mortality. JAMA 1997; 277: 301-6.
2. Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring - Cost and benefit considerations. Part II. Cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6: S79-S90.
3. Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres BMJ 2000; 7241: 1036.
4. Apretna E, Haramburu F, Taboulet F, Begaud B. Medical and socio-economical impact of drug-induced adverse reactions. Presse Med, 2005; 4: 271-6.